00687naa#a2200205#i#4500001001500000005001700015011001400032100004100046102000700087200012500094210008200219215001000301608002700311675005600338700001700394700001900411700001800430700001900448856001400467EN\\bibl\1809320251222173149.1##a2409-3750##a20170912b2017####ek#y0engy0150####ca##aRU1#aUSING OF DAPAGLIFLOZIN BY PATIENT WITH DIABETES MELLITUS TYPE 2   AND NON-ALCOHOLIC FATTY LIVER DISEASEeJournal article1#aTulacLLC Information and publishing center Innovations and investmentsd2017##a6 с.##aJournal article2local##aМедицина. Охрана здоровья. 61#1aPrilepagS A#1aMedvedevagE V#1aDail'nevgV I#1aMakishevagR T4#azh-szf.ru